bluebird bio (NASDAQ:BLUE) Now Covered by StockNews.com
Equities research analysts at StockNews.com initiated coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Several other research firms have also issued reports on BLUE. Baird R W lowered shares of […]
Equities research analysts at StockNews.com initiated coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Several other research firms have also issued reports on BLUE. Baird R W lowered shares of […]
